Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 543.35 USD | +1.06% |
|
-0.40% | -6.70% |
| 22/07 | BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542 | MT |
| 21/07 | Madrigal Pharmaceuticals Insider Sold Shares Worth $1,368,253, According to a Recent SEC Filing | MT |
| Market Cap | 1.25TCr 1.1TCr 1.02TCr 941.38Cr 1.77TCr 1,21300Cr 1.8TCr 12TCr 4.77TCr 59TCr 4.7TCr 4.6TCr 2,05300Cr | P/E 2026 * |
-74.2x | P/E 2027 * | 63.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2TCr 1.06TCr 981.45Cr 902.66Cr 1.69TCr 1,16300Cr 1.72TCr 12TCr 4.58TCr 57TCr 4.51TCr 4.41TCr 1,96800Cr | EV / Sales 2026 * |
8.02x | EV / Sales 2027 * | 5.25x |
| Free-Float |
94.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +1.06% | ||
| 1 week | -0.40% | ||
| Current month | +1.19% | ||
| 1 month | +5.83% | ||
| 3 months | +4.74% | ||
| 6 months | +13.09% | ||
| Current year | -6.70% |
| 1 week | 526.6 |  | 555.05 |
| 1 month | 505.05 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% | ||
| 17/06/26 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% | |
| 17/06/26 | Free | Director | 1,220 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | -0.40% | +77.13% | +151.84% | 1.25TCr | |
| +1.23% | +0.35% | +51.62% | +87.98% | 5.59TCr | |
| +1.56% | +7.53% | +63.68% | +68.85% | 5.67TCr | |
| +0.25% | +0.55% | -19.67% | -15.22% | 2.33TCr | |
| +0.72% | -0.05% | +3.84% | +409.54% | 2.33TCr | |
| -1.33% | +4.60% | +29.58% | -4.61% | 2.05TCr | |
| -0.60% | +1.44% | +26.19% | -29.62% | 1.78TCr | |
| -2.21% | +4.75% | +31.38% | +538.47% | 1.59TCr | |
| -2.54% | -8.73% | +164.11% | +289.45% | 1.46TCr | |
| +1.22% | -0.05% | +22.58% | +182.63% | 1.4TCr | |
| Average | -0.09% | +1.10% | +45.04% | +167.93% | 2.55TCr | |
| Weighted average by Cap. | +0.36% | +3.00% | +44.73% | +136.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 149.84Cr 131.79Cr 122.43Cr 112.6Cr 211.17Cr 15TCr 214.95Cr 1.46TCr 571.04Cr 7.08TCr 562.54Cr 550.37Cr 25TCr | 217.96Cr 191.7Cr 178.09Cr 163.79Cr 307.16Cr 21TCr 312.67Cr 2.13TCr 830.63Cr 10TCr 818.27Cr 800.57Cr 36TCr |
| Net income | -21Cr -18Cr -17Cr -16Cr -30Cr -2.03TCr -30Cr -204.8Cr -80Cr -990.14Cr -79Cr -77Cr -3.44TCr | 26Cr 23Cr 22Cr 20Cr 37Cr 2.56TCr 38Cr 257.81Cr 100.56Cr 1.25TCr 99Cr 97Cr 4.32TCr |
| Net Debt | -52Cr -45Cr -42Cr -39Cr -73Cr -4.99TCr -74Cr -503.31Cr -196.32Cr -2.43TCr -193.4Cr -189.21Cr -8.44TCr | -107.6Cr -95Cr -88Cr -81Cr -151.64Cr -10TCr -154.35Cr -1.05TCr -410.06Cr -5.08TCr -403.96Cr -395.22Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $543.35 | +1.06% | 1,60,514 |
| 22/26/22 | $537.65 | -1.67% | 3,10,899 |
| 21/26/21 | $546.79 | +2.07% | 2,22,279 |
| 20/26/20 | $535.69 | -3.21% | 2,23,809 |
| 17/26/17 | $553.48 | +1.46% | 5,28,309 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
